Kisqali.com - KISQALI (ribociclib) Professional Site | KISQALI (ribociclib) for HR+, HER2- Metastatic Breast Cancer

Webseite besuchen

KISQALI is indicated for the treatment of women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior end

Platzierung

Noch nicht platziert

Votes

Noch keine erhalten

Beliebt seit

15.08.2018